Clinical Trials
5 trialsNCT04549207 2026-04-07
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT00128297 2023-03-28
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT02721433 2020-12-02
REaCT-BTA
Ottawa Hospital Research Institute
Phase 4 Completed
NCT01907880 2017-07-07
ER11-03
Ottawa Hospital Research Institute
Phase 4 Completed
NCT01067989 2015-07-08
Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
HaEmek Medical Center, Israel
Phase 2 Terminated